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. There is an exquisitely specific requirement for Wnt9a in directing an early amplification of haematopoietic stem and progenitor cells (HSPCs), a surprising finding because Wnts have been thought to be functionally promiscuous [2] [3] [4] [5] . Using HSPC development as a platform for validation, we demonstrate that the epidermal growth factor receptor (EGFR; also known as ERBB1) is required as a cofactor to mediate the specificity of the Wnt9a-Fzd9b signalling interaction, a finding that may indicate a general paradigm for Wnt-Fzd signalling specificity.
Haematopoietic stem cells (HSCs) are the tissue-specific stem cells that provide blood and immune cells for the duration of an organism's life. During development, these cells arise directly in major arterial vessels, from a specialized population of cells termed haemogenic endothelium (HE), specified from progenitors in the lateral plate mesoderm 6, 7 . HE cells receive inductive cues from nearby tissues, such as the somite and neural crest cells, including fibroblast growth factors, Notch and Wnt, to establish their fate and future function as HSPCs [6] [7] [8] [9] [10] [11] [12] . After their specification, HSPCs emerge directly from the endothelium comprising the ventral floor of the dorsal aorta (hereafter aorta) in a process termed the endothelial-to-haematopoietic transition 13, 14 . They then enter the circulation and migrate to secondary haematopoietic organs, such as the fetal liver in mammals or the caudal haematopoietic tissue in teleosts, before seeding the final sites of residence in the bone marrow of mammals or the kidney marrow of teleosts 6, 7 .
Wnts are important to HSPC development and homeostasis [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] . We previously determined that an early Wnt9a cue is specific in driving a proliferative event in the aorta, after HSCs have emerged, but before they have seeded the secondary haematopoietic organs. We hypothesized that this specific function of Wnt9a may be mediated through specific interaction with one of the 14 zebrafish Fzd receptors 3 .
Here, we identify Fzd9b as the cognate signalling partner for Wnt9a in the process of HSPC development, upstream of β-catenin, a process conserved in human haematopoiesis in vitro. Intracellular Fzd9b domains mediate the specificity of this Wnt-Fzd pairing, implicating a transmembrane spanning cofactor in establishing specificity. Using APEX2-mediated proximity labelling 27 , we identified the receptor tyrosine kinase EGFR as being required for this specific signalling interaction. Altogether, these results demonstrate a conserved Wnt-Fzd pairing that mediates a precise Wnt cue required for haematopoiesis, shifting the paradigm of how specific Wnt-Fzd interactions are established and opening the field for discovery of other cofactors that mediate specific signalling through cognate Wnt-Fzd pairs.
Results
HSPCs require Fzd9b-Wnt9a interaction. Specificity of Wnt signals probably involves Wnt-Fzd pairings; we sought to identify a cognate Fzd for the specific Wnt9a signal, which occurs when the somite signals to ingressing HE precursors before 20 h postfertilization (hpf) 3 . A fzd expression screen in 16.5 hpf Fli1a
+ (endothelial) cells indicated that a majority of genes encoding Fzds were expressed ( Supplementary Fig. 1a,b) . As the Wnt9a signal involves β-catenin 3 , we employed an established β-catenin-dependent Wnt EGFR is required for Wnt9a-Fzd9b signalling specificity in haematopoietic stem cells Stephanie Grainger 1 Articles Nature Cell Biology reporter assay 28 , called Super-TOP-Flash (STF), to identify Fzd candidates. STF reporter activity indicated a synergistic interaction between Wnt9a and Fzd5, or Wnt9a and Fzd9b, but no other Fzd ( Fig. 1a and Supplementary Fig. 1c,d ). Wnt9a signals to its cognate receptor on neighbouring cells, which we assessed using a co-culture approach (Fig. 1b) . In this assay, Fzd9b, but not Fzd5, was able to transduce the Wnt9a signal and activate STF reporter activity (Fig. 1c) , indicating that Fzd9b acts as a specific Wnt9a receptor. These observations were further supported by an absence of signal using the Super FOP:FLASH reporter (a reporter lacking β-catenin activity; Supplementary Fig. 1e ), and an absence of Fzd9b-specific signal in response to the prototypical ligand Wnt3a ( Supplementary  Fig. 1f ). Altogether, these data provide evidence for a Wnt9a-Fzd9b interaction and indicate that Fzd9b is specifically involved in Wnt9a-mediated HSPC development.
Consistent with a role in Wnt9a signal reception, using fluorescent in situ hybridization (FISH), we found that at 15 hpf, fzd9b mRNA is co-expressed with the endothelial marker fli1a in the lateral a, STF assay screen with zebrafish Wnt9a (zWnt9a) and zFzds (n = 3 biological replicates for each). b,c, zWnt9a cells were mixed with zFzd9b or zFzd5 STF cells and assayed for Wnt activity (b) and quantified in c (n = 3 biological replicates for each). d, FISH for fzd9b (green) and fli1a (purple) in 15 hpf zebrafish embryos; DAPI is blue. ALPM, anterior lateral plate mesoderm; MLPM, medial lateral plate mesoderm; PLPM, posterior lateral plate mesoderm. Scale bar, 10 µm. The diagram on the right shows haematopoietic precursors (green), vascular precursors (blue) and fzd9b expression (purple). e, Cells emerging from the aorta (A) labelled by fzd9b:Gal4; UAS:GFP at 40 hpf. V, vein. Scale bar, 10 µm. f, Thymus (T) cells labelled by fzd9b:Gal4; UAS:GFP at 6 dpf. OV, otic vesicle. Scale bar, 25 µm. g,h, WISH for cmyb at 40 hpf in fzd9b morphants and controls (g) and quantified in h. Each dot represents a biological replicate; n = 32 control, n = 30 MO (h). Scale bar, 30 µm (g). In d-g, images are representative of 10 embryos examined in 3 independent experiments. i, qPCR for cmyb (black) and runx1 in fzd9b morphants (n = 3) and controls (n = 3) at 40 hpf. j, Quantification of WISH for cmyb at 40 hpf in fzd9b mutants (n = 4) and controls (n = 5). Each dot represents a biological replicate. k, qPCR for cmyb in fzd9b mutants (n = 3) and controls (n = 3) at 40 hpf. In all graphs, the dots represent biological replicates from a single experiment, the bars represent the mean and the error bars represent the standard deviation. All STF assays were repeated independently with a similar trend. All qPCR data were generated from biological replicates from dissected trunks and tails. Statistical analyses were done by ANOVA compared to controls as indicated. NS, not significant.
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Nature Cell Biology plate mesoderm, the tissue from which HE is derived 6, 7 (Fig. 1d) . To test whether haematopoietic cells were derived from cells expressing fzd9b, we performed two lineage tracing experiments using fzd9b promoter sequences driving expression of Gal4. First, Gal4 activates an upstream activating sequence (UAS)-driven green fluorescent protein (GFP) (fzd9b:Gal4; UAS:GFP); second, UAS:Cre is activated to excise a loxP-flanked sequence encoding blue fluorescent protein (BFP), ultimately leading to expression of dsRed (fzd9b:Gal4; UAS:Cre; loxP-BFP-loxP-dsRed). Using this strategy, we were able to observe GFP + or dsRed + (pseudo-coloured green in Supplementary  Fig. 2a ) cells in the floor of the dorsal aorta in the characteristic cup shape observed during the endothelial-to-haematopoietic transition (at 40 hpf), indicating that nascent HSPCs had expressed fzd9b prior to their emergence ( Fig. 1e and Supplementary Fig. 2a, left) . Thymocytes derived from HSCs reside in the thymus beginning around 4 d post-fertilization (dpf); these cells expressed GFP at 6 dpf and 7 dpf (Fig. 1f and Supplementary Fig. 2a, right) , consistent with a function for fzd9b in HSPC development. 
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To assess the function of Fzd9b in zebrafish HSPC development, we used an antisense morpholino (MO) oligonucleotide, which blocked translation of an ectopically provided Fzd9b-mKate fusion transcript in vivo (Supplementary Fig. 2b ). Similar to wnt9a loss of function 3 , fzd9b morphants had normal specification, as measured by the early HSPC marker runx1 ( Supplementary Fig. 2c,d) ; however, HSPC expansion markers (cmyb, gata2b and runx1) were significantly reduced in fzd9b morphants at 40 hpf (Fig. 1g-i and Supplementary Fig. 2e,f) . This loss of HSPCs persisted throughout development, where Rag1 + thymocytes were reduced in fzd9b morphants ( Supplementary Fig. 2g ). This effect was specific to HSPCs, as markers for the aorta (dlc, dll4 and notch1b), vasculature (kdrl) and pronephros (cdh17) were normal ( Supplementary Fig. 2h ). The effects of the MO were specific, as the fzd9b MO could be rescued with fzd9b mRNA (Supplementary Fig. 2i,j) , and two germline mutants of fzd9b (predicted to produce severely truncated proteins of approximately 30 residues) had reduced Cmyb + cells at 40 hpf (Fig. 1j,k) . Furthermore, MO-injected fzd9b mutants did not have a more severe phenotype than their siblings (Supplementary Fig. 2k ). Finally, we used an established transgenic approach in which a guide RNA to fzd9b is expressed ubiquitously and Cas9 (encoding CRISPR-associated protein 9) expression is spatially regulated to conditionally inactivate fzd9b in early endothelial cells 29 , where the number of Cmyb + cells at 40 hpf was also reduced ( Supplementary  Fig. 2l,m) . Taken together with our finding that the Wnt signal is received by HE 3 , these results indicate that Fzd9b is required for HSPC development, downstream of fate specification, and specifically within HE.
Having identified a specific zebrafish Wnt9a-Fzd9b signal in vivo, we used the STF reporter assay and determined that only human FZD9 coupled effectively with WNT9A (Fig. 2a) . Furthermore, using an established differentiation protocol to drive human embryonic stem cells towards haematopoietic fates 30 ( Fig. 2b) , we found that disrupting WNT9A or FZD9 expression using short hairpin RNAs (shRNAs) ( Supplementary Fig. 3a ,b) significantly compromised the ability of human embryonic stem cells to generate HSPCs, as assessed by flow cytometry for CD34 and CD45 (Fig. 2c-f ) and by expression of endothelial (CD34) and haematopoietic markers (CD31, CD45 and CMYB) ( Supplementary Fig. 3c-f ). These differences were not due to loss of pluripotency of the undifferentiated human embryonic stem cells, as they still abundantly expressed the pluripotency markers TRA1-81 and SSEA4 (ref.
31
) ( Supplementary  Fig. 3g-i) . Thus, Wnt9a-Fzd9b and WNT9A-FZD9 are required for both zebrafish and human HSPC development.
Fzd9b-Wnt9a operate upstream of β-catenin. To confirm that Wnt9a and Fzd9b function in the same pathway in vivo, we used genetic non-complementation with suboptimal MO dosages. A low dose of either wnt9a or fzd9b MO was not sufficient to affect HSPCs, whereas compound morphant animals had a reduction in the number of Cmyb + cells similar to either wnt9a or fzd9b loss of function, supporting that these components operate in the same genetic pathway (Fig. 2g and Supplementary Fig. 4a ).
The effect of Wnt9a on HSPCs required β-catenin (encoded by ctnnb1; or the canonical Wnt pathway) 3 , which relies on the assembly of Fzd-LRP5/6 heterodimers in response to a Wnt ligand 1 . Consistent with this, the Wnt9a-Fzd9b signal could be synergistically increased in vitro in cells co-transfected with LRP6 ( Supplementary Fig. 4b ). To test the requirement for LRP6 in the Wnt9a-Fzd9b signal, we generated a HEK293T STF line deficient for LRP6 (Fig. 2h ), which were compromised in their STF reporter activity following the addition of WNT3A ( Supplementary Fig. 4c ). Importantly, treatment with a glycogen synthase kinase 3 (GSK3) inhibitor (CHIR98014), which activates signalling independent of Wnt-Fzd-LRP interactions, stimulated STF activity, indicating that downstream signalling components were intact ( Supplementary  Fig. 4d ). Wnt9a-Fzd9b signalling also required LRP6 (Fig. 2i) , consistent with a role upstream of β-catenin. Accordingly, loss of fzd9b, the putative Wnt9a receptor, should be rescued by expression of constitutively active (CA) β-catenin. Indeed, HE-specific regulatory sequences (gata2b promoter) driving expression of CA-β-catenin , the Fzd9b CRD is required to mediate the Wnt9a signal in vitro (Fig. 3a) . Signalling differences were not due to differences in protein expression ( Supplementary Fig. 5a ).
We next sought to determine which domains are required for Wnt9a-Fzd9b signalling specificity by constructing a series of chimaeric Fzd transgenes between Fzd9b and Fzd8a, which is a Fzd that did not activate STF reporter activity with Wnt9a (Fig. 1a) . Surprisingly, a chimaeric receptor in which the CRD of Fzd8a was replaced with that of Fzd9b did not signal (Fig. 3b) , whereas the opposite chimaeric Fzd protein produced wild-type Wnt9a signalling activity (Fig. 3b) , suggesting that other Fzd domains other than the CRD are critical determinants in Wnt9a-Fzd9b signalling specificity.
The signalling events downstream of the Wnt-Fzd-LRP interaction are thought to involve interaction with intracellular mediator proteins such as Dishevelled (Dsh; also known as Dvl), which interacts with Fzd at the third intracellular loop (ICL3) and the carboxy-terminal tail (CTT) 1 . Using further Fzd9b-Fzd8a chimaeras, we found that substituting both the ICL3 and the CTT from Fzd9b with those of Fzd8a was sufficient to completely ablate the signal, and the opposite was sufficient to produce wild-type signalling levels ( Fig. 3b) , whereas single substitutions resulted in partial levels of signalling ( Fig. 3b) , suggesting that signalling specificity for Wnt9a-Fzd9b lies entirely within the ICL3 and CTT domains. These chimaeras were expressed to the same level ( Supplementary Fig. 5b ), indicating that differences in signalling were not due to differences in expression. These findings were recapitulated using zebrafish and human cDNAs encoding chimaeras for Fzd9b-FZD9 and Fzd4-FZD4 ( Supplementary Fig. 5c,d ), indicating that the ICL3 and the CTT are required for zebrafish Fzd9b and human FZD9 signalling.
V5-tagged Fzd constructs had no change in the ability to mature or be modified post-translationally ( Supplementary Fig. 5b) , as assessed by their shift in size in immunoblots [35] [36] [37] . We also confirmed that the non-signalling chimaeric Fzd9bs were transported to the cell surface using immunofluorescence and flow cytometry with a Fzd9b antibody directed to the extracellular region between the CRD and the first transmembrane domain of Fzd9b ( Supplementary Fig. 5d-f) . Thus, differences in signalling were not due to differences in Fzd protein expression, maturation or transport to the cell surface.
Finally, to determine whether these domains were able to fulfil Fzd9b function in HSPC development, we co-injected fzd9b, fzd8a 
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Nature Cell Biology or fzd8a mRNAs with the ICL3 and the CTT from fzd9b (fzd8a/9b ICL3/CTT) in the context of fzd9b MO, and found that only fzd9b and fzd8a/9b ICL3/CTT were able to rescue loss of fzd9b (Fig. 3c,d ). Taken together, these data indicate that Wnt9a-Fzd9b specificity is regulated by the intracellular ICL3 and CTT domains of Fzd9b.
Wnt9a, Fzd9b and EGFR form a complex. As Wnt9a-Fzd9b specificity is mediated intracellularly, we postulated the existence of another signalling component that spanned the membrane to contact both Wnt9a and the intracellular portion of Fzd9b. Our ability to analyse Wnt9a-Fzd9b signalling specificity using zebrafish cDNAs in human cells further suggested that this signalling component would be highly conserved. To identify proteins that are in proximity to intracellular portions of Fzd9b, we generated a stable HEK293T cell line expressing Fzd9b fused via a glycine-serine linker to the peroxidase APEX2 (ref.
27
) (Fzd9b-5GS-APEX2). In the presence of hydrogen peroxide and biotin-phenol, endogenous proteins proximal to APEX2 (generally within 30 nm) are biotinylated within 1 min, allowing for their enrichment with streptavidin beads and subsequent identification by mass spectrometry (MS) 27 . The Fzd9b-5GS-APEX2 cells, labelled specifically in the presence of biotin-phenol and hydrogen peroxide induction ( Supplementary Fig. 6a ), had correct Fzd9b localization ( Supplementary Fig. 6b ,c) and were able to signal in response to Wnt9a (Supplementary Fig. 6d ).
Gene ontology (GO) analysis of the APEX-MS data revealed that in response to Wnt9a, the most changed biological processes included ERBB signalling ( Supplementary Fig. 6e) . Genes from the ERBB family encode single-pass transmembrane receptor tyrosine kinases that homodimerize and heterodimerize in response to multiple ligands to stimulate numerous signalling cascades 38 . The transmembrane protein most enriched by proximity labelling was EGFR (Supplementary Fig. 6f ). We hypothesized that EGFR may play a CTTs from species shown, using ClustalOmega; * indicates complete conservation, : indicates conservation between highly similar residues, . indicates conservation with with partially similar residues. c, Immunoblot (IB) for V5 from phosphotyrosine (pTyr) immunoprecipitation (IP) with increase in pY-zFzd9b (2.98 versus 1, arbitrary units). A trend was observed in four independent experiments. See also Supplementary Fig. 7 . inh, inhibitor. d, STF assay of zFzd9b point mutants (n = 9, 14, 10 and 6 from left to right). e, Quantification of WISH for Cmyb + cells in uninjected, fzd9b MO injected and fzd9b MO + fzd9b Y556F mRNA injected fish at 40 hpf (n = 10 zebrafish each). f, Quantification of the HEK293T cell STF assay with human WNT9A and FZD9 WT and Y562F mutant (n = 3 biological replicates each). In all graphs, the dots represent biological replicates from a single experiment, the bars represent the mean and the error bars represent the standard deviation. Statistical analyses were done by ANOVA compared to control as indicated. All STF assays were repeated independently with a similar trend.
Articles
Nature Cell Biology role in Wnt9a recruitment to Fzd9b at the cell membrane. Indeed, disrupting EGFR expression in HEK293T cells stably expressing Fzd9b with short interfering RNA (siRNA) reduced cell-surface binding of Wnt9a (Fig. 4a) , suggesting that EGFR expression promotes Wnt9a binding to the cell surface. Interestingly, this also occurred in the absence of Fzd9b (Fig. 4a) , suggesting that Wnt9a See Methods for analysis and statistics. b, Heatmap of Fzd9b-APEX2 proximity labelled normalized intensities of RAB members in the early endosome, late endosome and recycling endosome over time from n = 3 biological replicates. Tx, treatment. c, zFzd9b-APEX2 proximity labelled normalized intensity averages of three biological replicates. d, STF assay with zWnt9a and zFzd9b cultured with chlorpromazine (CPZ) (n = 3 experiments each). e, STF assay of hWNT9A CHO/hFZD9 STF co-culture treated with CPZ (n = 3 experiments each). In all graphs, the dots represent biological replicates from a single experiment, the bars represent the mean and the error bars represent the standard deviation. Statistical analyses were done by ANOVA compared to control as indicated. All STF assays were repeated independently with a similar trend. f, Fzd9b, LRP6 and EGFR are resident in proximity at the cell surface (1). The destruction complex targets β-catenin for degradation in the absence of a ligand (2) . In the presence of Wnt9a, EGFR phosphorylates the Fzd9b tail at Y556 (3). AP-2 and clathrin are recruited (4). Fzd9b-LRP6 oligomerization leads to dissociation of the destruction complex and release of β-catenin into the cytosol, allowing for nuclear translocation (5). Nuclear β-catenin transactivates a programme for HSC proliferation (6).
Nature Cell Biology binds directly to EGFR. In addition, treatment with cetuximab 39 , which blocks the ligand binding to EGFR, dampened the Wnt9a-Fzd9b signal (Fig. 4b) , consistent with a model in which EGFR forms a complex with Wnt9a and Fzd9b to transmit the Wnt signal.
HEK293T cells transfected with siRNA to EGFR compromised the ability of both zebrafish and human Wnt9a-WNT9A and Fzd9b-FZD9 to stimulate STF reporter activity ( Supplementary Fig. 6g ,h and Fig. 4c ). Using a previously validated MO to egfra 40 , the number of HSPCs at 40 hpf was decreased ( Supplementary Fig. 6i,j) , an effect that was validated with quantitative PCR (qPCR) (Fig. 4d) , similar to the phenotypes of fzd9b or wnt9a loss of function, and consistent with a role for Egfr in regulating the Wnt9a-Fzd9b signal. Suboptimal MO dosing indicated that both Fzd9b and Wnt9a synergize genetically with Egfr during HSPC development (Fig. 4e) . Furthermore, treatment of cells or zebrafish with the selective EGFR tyrosine kinase inhibitor AG1478 (ref. 41 ) significantly attenuated STF reporter activity or HSPC development, respectively ( Supplementary Fig. 6k,m) .
Altogether, these data demonstrate that EGFR and its kinase activity are required for the Wnt9a-Fzd9b signal.
There are seven other known ligands for EGFR 38 , which led us to hypothesize that these may be required to assemble EGFR, Wnt9a and Fzd9b into a complex. Of these, only heparin-bound EGF (HBEGF) is expressed in HEK293T cells 42 ( Supplementary Fig. 6n ). To assess the requirement for HBEGF and other EGFR ligands in the Wnt9a-Fzd9b signal, we cultured HEK293T STF reporter cells in serum-free media lacking all known EGFR ligands and added a neutralizing antibody targeting HBEGFR. STF reporter activity with Wnt9a-Fzd9b stimulation was maintained in these conditions ( Supplementary Fig. 6o ), indicating that this interaction occurs independently of known EGFR ligands.
The CTT of Fzd9b contains two tyrosine (Y) residues, at 556 and 571 (Fig. 5a ), which are predicted to be potential kinase substrates 43 . In addition, the Y556 on Fzd9b is highly conserved among vertebrates, indicative of putative functional importance (Fig. 5b) . Consistent with these predictions, treatment with Wnt9a increased tyrosine phosphorylation of Fzd9b, which was dependent on EGFR kinase activity, as this increase was not observed in the presence of the EGFR tyrosine kinase inhibitor AG1478 (Fig. 5c) . Furthermore, mutation of the Y556 (but not the Y571) sites decreased the in vitro signalling capacity of Wnt9a (Fig. 5d ) and was not able to rescue fzd9b morphants (Fig. 5e) ; we also found that the corresponding residue in human FZD9, Y562F, is required (Fig. 5f ). Together, these data indicate that Fzd9b is phosphorylated on Y556 in response to Wnt9a, which is required for its downstream signal.
EGFR is known to have effects on signal transduction, as well as receptor internalization and trafficking [44] [45] [46] . Consistent with these functions, GO analysis of the APEX-MS data indicated that the most enriched cellular component was the 'clathrin-coated endocytic vesicle' (Fig. 6a) . The APEX data also showed enrichment for proteins associated with early endosomes (RAB5A, RAB5B, RAB5C and RAB14), late endosomes (RAB7A, RAB9A and RAB12) and recycling endosomes (RAB11B, RAB35 and RAB13) (Fig. 6b) , consistent with Fzd9b internalization in response to Wnt9a.
Internalization of transmembrane proteins can be mediated by clathrin-mediated or caveolin-mediated endocytosis, as can FzdWnt complexes 47, 48 . The APEX-MS data indicated that the AP-2 complex and clathrin-mediated endocytosis machinery were recruited to Fzd9b in response to Wnt9a, suggesting that internalization was mediated by clathrin (Fig. 6c) . Indeed, clathrin was required for both the zebrafish Wnt9a-Fzd9b and human WNT9A-FZD signals, as STF activity was reduced in the presence of the clathrin inhibitor chlorpromazine (Fig. 6d,e) . These results indicate that Fzd9b is internalized and sorted through the endolysosome in response to Wnt9a.
Taken together, our data indicate a mechanism for the specificity of Wnt9a-Fzd9b signalling and a role for EGFR in directly regulating this Wnt signal. Fzd9b, LRP6 and EGFR are resident in proximity at the cell surface (Fig. 6f, (1) ); in the absence of a ligand, β-catenin is targeted for proteasomal degradation by the destruction complex (Fig. 6f, (2) ); in the presence of Wnt9a, these are bridged, allowing EGFR-mediated phosphorylation of the Fzd9b tail at Y556 (Fig. 6f,  (3) ), leading to the recruitment of AP-2 and clathrin (Fig. 6f, (4) ). Once inside the cell, Fzd9b-LRP6 oligomerization leads to dissociation of the destruction complex and the release of β-catenin (Fig. 6f,  (5) ). Finally, nuclear β-catenin transactivates a programme for HSC proliferation (Fig. 6f, (6) ).
Discussion
One longstanding puzzle in the Wnt field has centred around the requirement for genetically encoding such a diverse set of ligands and receptors if Wnt ligands are as promiscuous as reported 4, 33, 49 . The specificity dogma has been that Wnt-Fzd interactions are regulated by (1) . In addition, (3) the ligand availability in the extracellular space is regulated by co-receptors, such as Reck and Gpr124 (refs. [51] [52] [53] [54] ), in a mechanism distinct from our findings. Our data indicate that signalling specificity is regulated at an additional level involving the activation of co-receptors. To this model, we propose the addition of (4) cofactors enzymatically activating Wnt-Fzd complexes for signalling through internalization. We hypothesize that different cofactors are recruited extracellularly by specific WntFzd pairs to target the receptor complex for signalling. These results support the notion that the specificity of Wnt-Fzd pairs relies on co-receptor complexes; however, the concept that Wnt stimulation recruits a co-receptor (EGFR), leading to its enzymatic regulation of the Fzd intracellular domains (tyrosine phosphorylation) and subsequent internalization for signalling, is unprecedented.
These discoveries have important implications in our understanding of development and disease, where overlapping functions of receptor tyrosine kinase families and Wnt, for example, may represent co-operative functions in signalling. Understanding Wnt-Fzd and cofactor-specific interactions will be critical to the advancement of regenerative medicine, such as in the development of protocols to derive different tissues in vitro from pluripotent precursor cells, where in large part, the requirement for β-catenin-dependent Wnt signalling in these protocols has been substituted with the prototypical ligand Wnt3a, or with GSK3 inhibitors, and not a specific ligandreceptor. Finally, determining how individual WNTs and FZDs are coupled will have important therapeutic implications, where pan-WNT inhibitory therapies cause toxic side effects. Furthermore, our observation that cetuximab, which blocks ligand binding to EGFR, disrupts Wnt9a-Fzd9b (WNT9A-FZD9 in humans) signalling suggests potential alternative mechanisms of action for this chemotherapeutic agent. Therapies targeting specific WNT-FZD pairs will allow for more precise targeting of these cancer cells.
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Methods
Cell culture and luciferase reporter assays. HEK293T cells or HEK293T cells lacking FZD1, FZD2 and FZD7 (kindly provided by M. Boutros, German Cancer Research Center) 5 with a stably integrated STF 55 and Chinese hamster ovary (CHO) cells were grown in DMEM supplemented with 10% heat-inactivated FBS under standard conditions. HEK293T cells are known to have potential crosscontamination with HeLa cells (ICLAC Register of Misidentified Cell Lines (iclac. org/databases/cross-contaminations/)), which is irrelevant to this study.
For most assays, cells were seeded into six-well plates and transfected using polyethyleneimine (PEI), 50 ng renilla reporter vector, 200 ng cDNA expression vector, with a total of 1 µg DNA per well. For co-culture experiments, cells were passaged 24 h after transfection and plated together for analysis. For siRNA experiments, a well of a six-well plate was also treated with 10 pmol siRNA using RNAiMax transfection reagent (Invitrogen). All human WNT9A cell culture experiments except for the initial screen were performed by co-culturing stably expressing WNT9A CHO cells with stably expressing FZD9 HEK293T STF cells. Assays with Wnt3a were conducted in HEK293T cells lacking FZD1, FZD2 and FZD7 (ref. 5 ). Serum-free conditions were established by gradually adapting our HEK293T STF reporter cells to SFM II (Invitrogen), which lacks all known EGFR ligands. Serum-free transfections were performed according to the manufacturer recommendations using Lipofectamine 3000. HBEGF neutralizing antibody (500 ng ml −1 ; AF-259-SP, R&D systems) or normal goat serum (AB-108-C, R&D systems) were added 6 h after transfection.
All transfected cells were harvested 48-h post-transfection and all conditioned medium or co-cultured cells were harvested 24-h post-treatment; the lysates were processed and analysed using the Promega Dual Luciferase Assay System according to the manufacturer's instructions. Each experiment was performed with at minimum triplicate biological samples and reproduced at least once with a similar trend. Wnt activity was calculated by normalizing firefly luciferase output to Renilla luciferase; maximum fold induction was set to 100%. All STF reporter assays were conducted with a minimum of three biological replicates; the assays were always reproduced with a similar trend at least once.
Plates (10 cm) of HEK293T cells were transfected with 10 µg constructs encoding chimaeric Fzd cDNAs with a C-terminal V5 tag. For immunofluorescence, cells were plated onto glass coverslips after 24 h and stained with our Fzd9b antibody, generated to a region between the CRD and the first transmembrane domain, under non-permeabilized conditions, and according to standard protocols. For flow cytometry, cells were harvested with Accutase, pelleted, resuspended in PBS with 1% BSA and 1 mM EDTA, filtered through an 80-µm filter and sorted using a BD Fortessa flow cytometer. For immunoblots, cells were harvested 48 h after transfection in TNT buffer (1% Triton X-100, 150 mM NaCl and 50 mM Tris, pH 8) with protease inhibitors. Immunoblotting was performed according to standard procedures, using antibodies against V5 (1:5,000; GTX628529, GeneTex) and β-actin (1:20,000; A2228-100UL, Sigma).
For immunoprecipitation, cells were washed three times in PBS and lysed in RIPA buffer (10 mM Tris-HCl, pH 8, 10 mM EDTA, 0.5 mM EGTA, 1% Triton X-100, 0.1% deoxycholate, 0.1% SDS and 140 mM NaCl), supplemented with protease and phosphatase inhibitor tablets (Pierce) and 20 mM N-ethylmaleimide for 30 min at 4 °C with rocking. Resultant lysates were cleared of cell debris by centrifugation at 15,000g for 10 min at 4 °C and quantified by Bradford Assay. A minimum of 200 µg protein was diluted in 400 µl total volume with RIPA buffer; 2 µg antibody was added and incubated at room temperature for 30-60 min. Antibody-protein complexes were precipitated using Protein A Dynabeads (Invitrogen) for 30 min at room temperature, washed three times with 1 ml RIPA buffer and eluted using Laemmli buffer at room temperature. Precipitates were analysed by Fzd9b immunoblot. Immunoblot intensities from pulldowns were quantified by densitometry using ImageJ, normalized to input controls.
EGFR inhibition was performed using a 5 mM stock of AG1478 in 50:50 ethanol:dimethylsulfoxide. The final concentration used was 2.5 µM. Clathrinmediated endocytosis was inhibited using chlorpromazine from a 1 M stock in 50:50 ethanol:dimethylsulfoxide. The final concentrations used are as indicated in the figure.
Wnt9a surface binding assay. Conditioned medium was collected from stably expressing Wnt9a or parental CHO cells and concentrated 10× using a 30-kDa molecular weight cut-off ultra-filtration device (Millipore). HEK293T cells stably expressing Fzd9b were transfected with control siRNA (siControl) or siEGFR and plated on 0.1% gelatin-coated glass coverslips after 24 h; after a further 24 h, cells were treated with cold conditioned medium for 3 h at 4 °C, rinsed with PBS and fixed with 4% paraformaldehyde at 4 °C for 20 min and at room temperature for 10 min. Immunofluorescence was performed using standard non-permeabilizing methods with a rabbit polyclonal antibody generated to zebrafish Wnt9a.
Generation of LRP6-knockout HEK293T STF line.
A confluent 10-cm plate of HEK293T STF cells was transfected with 3 μg each of Cas9 and two guide RNAs under regulatory control of a U6 promoter. The guide RNAs (GGGCTTGGAGGATGCAGCTG and GGATCTAAGGCAATAGCTCT) targeted the second exon of LRP6. Single-cell clones were validated for loss of LRP6 by sequencing the genomic locus, immunoblotting using a rabbit monoclonal antibody (1:1,000, C47E12; 2560S, Cell Signalling) and STF activity with mouse WNT3A, which requires LRP6 for signalling 35 . Cell lines are available on request.
Fzd9b and Wnt9a antibody generation. Glutathione S-transferase fusion proteins for immunogens of Fzd9b (residues 115-226) and Wnt9a (residues 233-295) were purified by standard methods. Rabbits were immunized with glutathione Stransferase proteins, boosted and bled for serum according to standard methods (Lampire Biologicals). Antibodies against Wnt9a or Fzd9b were affinity purified against the same antigens fused to maltose-binding protein, according to the manufacturer's recommendations (Fisher), and stored in PBS/50% glycerol at −80 °C. Antibodies are available on request. MO for fzd9b was targeted to block the ATG start codon with sequence 5′-AGGTGAGCTTCCCATTCTGGATTTT-3′ from GeneTools. One-cell-stage zygotes were injected with 2 ng fzd9b MO, and disruption of protein expression was confirmed with a fluorescently tagged mRNA. Suboptimal MO dosage was 0.5 ng. The wnt9a MO has been previously described 3 and was used at 0.1 ng. The egfra MO has been previously described 40 and was used at 2.5 ng or 1 ng. Rescue experiments were performed using 20 pg fzd chimaeric mRNA synthesized using the SP6 mMessage machine kit (Ambion) according to the manufacturer's recommendations.
Animals
Clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 was used to generate germline mutants for fzd9b; single guide RNAs were chosen according to their ability to cleave DNA in vitro as previously described 56 . Mutation of the fzd9b locus at the amino-terminal was achieved using 100 ng cas9 mRNA (Trilink) and 100 ng single guide RNA (GGCTCTTATGACCTGGAGAG) and generated mutants with either a 2-bp insertion (fzd9b Tg(fzd9b:Gal4) founders were established by injecting 25 pg of a Tol2 kit 57 generated plasmid with 100 pg transposase mRNA at the one-cell stage. The transgenic plasmid encoded a 4.3-kb fzd9b promoter region amplified using the primers: 5′-CTCCCATGAGGCAGAACGTGTGT-3′ and 5′-AGTCCGCGAGCAGCTTGTCTGTT-3′; this was cloned into a p5E MCS Tol2 entry vector using XhoI and SacII restriction sites and then combined with a Gal4 middle entry and polyA 3′ entry vector by Gateway assembly to make a full transgene construct with cmlc2:gfp in the backbone. The resultant animals were crossed to Tg(UAS:YFP), and the expression was compared to in situ hybridization for fzd9b to identify founders that recapitulated endogenous fzd9b expression.
Lineage tracing experiments were visualized on a Zeiss LSM 880 with Airyscan. Representative images were produced by combining 3-4 Z-slices per scan.
Whole-mount in situ hybridization and FISH. RNA probe synthesis was carried out according to the manufacturer's recommendations using the DIG-RNA labelling kit, or the fluorescein labelling kit for FISH (Roche). Probes for fli1a, rag1, dll4, dlc, notch1b, kdrl, cdh17, cmyb and runx1 and whole-mount in situ hybridization (WISH) protocols have been previously described 11 . The probe for fzd9b was generated from the full-length cDNA. The FISH signal was developed as previously described.
FACS and qPCR.
Zebrafish were dissociated using Liberase TM (Roche) and filtered through an 80-µm filter. Cells were sorted on a BD Influx cell sorter according to standard procedures. RNA and cDNA were synthesized by standard means and qPCR was performed using FastStart Universal SYBR Green Master Mix (Roche) according to the manufacturer's recommendations and analysed using the 2 −ΔΔCt method, as previously described 
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Data collection
Raw spectral data were processed using Proteome Discoverer 2.1.0.81 (Thermo).
Data analysis MS2 spectra were identified using the Sequest HT node, searching against the Human Uniprot database (downloaded: 5/11/2017) with the zebrafish Fzd9b sequence appended. False discovery rate (FDR) estimation was performed using a reverse decoy database. Search parameters were as follows. Mass tolerances were set to 50 ppm and 0.6 Da for MS1 and MS2 scans, respectively. Full trypsin digestion was specified with a maximum of two missed cleavages per peptide. Modifications included static 10-plex TMT tags on peptide n-termini and lysine, static carbamidomethylation of cysteine and variable oxidation of methionine. Data were filtered to a 1% FDR at both the peptide and protein level.
The intensities of TMT reporter ions were extracted from the MS3 scans for quantitative analysis. Prior to quantitation, spectra were filtered to have an average signal to noise of 10 across all labels and an isolation interference less than 25%. Data were normalized in a two-step process by normalizing each protein the pooled bridge channel value and then normalizing to the median of each reporter ion channel and the entire dataset.
Immunoblot intensities from pulldowns were quantified by densitometry using ImageJ 1.46, normalized to input controls.
GraphPad Prism 7.04 was used for statistical analyses.
Gene ontology of the significant proteins was performed using the database for annotation, visualization and integrated discovery (DAVID version 6.8) server.
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers. We strongly encourage code deposition in a community repository (e.g. GitHub All studies must disclose on these points even when the disclosure is negative.
Sample size
Based on preliminary studies, we determined that examining 5-10 fish and n=3-6 for luciferase assays are sufficient for at least 95% statistical power.
Data exclusions Samples were only excluded as outliers in the case of obvious error in instrument detection, or transfection failure. The exclusion criteria was pre-established as a zero-read on the instrument, or transfection efficiency lower than 20%, as measured by GFP+cells/total cells. Zebrafish cell counts were only excluded in case of staining failure.
Replication
To ensure reproducibility, all experiments were conducted with multiple samples, and reproduced successfully with a similar trend at least once. Replicates of luciferase assays that did not have sufficient transfection efficiency (more than 20%) did not signal. See figure legends for specific details.
Randomization Zebrafish offspring were pooled from several clutches and separated into control or experimental groups at random for injection experiments.
In the case of genetic experiments, randomization was not possible, but blinding (see below) was carried out.
Blinding
For zebrafish genetic experiments, heterozygous animals were crossed, and clutchmates were genotyped after experimental analysis (blinded). For MO injected fish, blinding was not performed. In luciferase reporter experiments, data was collected and analyzed blindly and labeled post analysis.
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We require information from authors about some types of materials, experimental systems and methods used in many studies. Here, indicate whether each material, system or method listed is relevant to your study. If you are not sure if a list item applies to your research, read the appropriate section before selecting a response. clone GT1071, cat#GTX628529 lot 41288), phospho-Y (1:1000, BioLegend, mouse monoclonal Clone PY20, cat#309301 lot B232939), LRP6 (1:2000, cell signaling, rabbit monoclonal C5C7, cat#2560S lot 11), B-actin (1:20,000, mouse monoclonal C47E12, Sigma, cat#A2228-100UL lot 058M4808), EGFR (1:1000, abcam, rabbit monoclonal EP38Y, cat#ab52894), HBEGF (500ng/mL, R&D systems, cat#AF-259-SP lot PX101812A) Mycoplasma contamination
All cell lines tested negative for mycoplasma contamination, with the exception of 293T TOP:FLASH reporter cells, which tested positive. This was controlled for by using the parental cells as the control group with matched levels of transfected DNA.
Commonly misidentified lines
(See ICLAC register)
HEK293 cells are known to have potential cross-contamination with HeLa cells. This was irrelevant to our study, as these cells were used only as a reporter of Wnt activity, where any cell line would be used.
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Laboratory animals
Zebrafish (Danio Rerio) were used; wild-type strain AB*, Tg(kdrl:Cherry-CAAX)y171, Tg(fli1a:eGFP)zf544, Tg(cdh5:Gal4)mu101, Tg(UAS:CA-β-catenin)sd47Tg Tg(gata2b:KalTA4sd32; UAS:Lifeact:eGFPmu271), wnt9ad28/d28,sd49, Tg(UAS:Cre)t32240Tg Tg(bactin2:loxP-BFP-loxP-DsRed)sd27.
Adult fish were mated between 3-15 months of age. Offspring were generated with a male x female cross; the sex of zebrafish embryos is not readily detectable, but a 50:50 distribution is assumed. Offspring ages are noted in each figure.
Wild animals
This study did not involve wild animals.
Field-collected samples
The study did not involve samples collected from the field.
Ethics oversight
Zebrafish were maintained and propagated according to University of California and local Institutional Animal Care and Use Committee (IACUC) policies.
Note that full information on the approval of the study protocol must also be provided in the manuscript.
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Methodology
Sample preparation cells were harvested with Accutase, pelleted, resuspended in PBS with 1% BSA and 1mM EDTA, filtered through an 80um filter and sorted using a BD Fortessa flow cytometer.
Instrument BD Fortessa LSR II
Software
Flow Jo (X.0.7) and FACS Diva (6) 
